01 1Edmond Pharma Srl
01 1Noradrenaline Bitartrate Monohydrate
01 1Sweden
NDC Package Code : 66583-0520
Start Marketing Date : 2016-06-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
A Norepinephrine l-Tartrate, (+)-Isomer manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Norepinephrine l-Tartrate, (+)-Isomer, including repackagers and relabelers. The FDA regulates Norepinephrine l-Tartrate, (+)-Isomer manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Norepinephrine l-Tartrate, (+)-Isomer API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Norepinephrine l-Tartrate, (+)-Isomer manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Norepinephrine l-Tartrate, (+)-Isomer supplier is an individual or a company that provides Norepinephrine l-Tartrate, (+)-Isomer active pharmaceutical ingredient (API) or Norepinephrine l-Tartrate, (+)-Isomer finished formulations upon request. The Norepinephrine l-Tartrate, (+)-Isomer suppliers may include Norepinephrine l-Tartrate, (+)-Isomer API manufacturers, exporters, distributors and traders.
click here to find a list of Norepinephrine l-Tartrate, (+)-Isomer suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Norepinephrine l-Tartrate, (+)-Isomer as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Norepinephrine l-Tartrate, (+)-Isomer API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Norepinephrine l-Tartrate, (+)-Isomer as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Norepinephrine l-Tartrate, (+)-Isomer and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Norepinephrine l-Tartrate, (+)-Isomer NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Norepinephrine l-Tartrate, (+)-Isomer suppliers with NDC on PharmaCompass.
We have 1 companies offering Norepinephrine l-Tartrate, (+)-Isomer
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
